Aged APP/PS1 transgenic mice, a model of AD, exhibit significantly lower EGFR expression than mice in the early stage of AD, resulting in increased Aβ plaques, memory loss, and neurodegeneration (70). This evidence concerns the gene EGFR and Alzheimer disease.